Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Depreciation & Amortization (CF): 2013-2019

Historic Depreciation & Amortization (CF) for Astria Therapeutics (ATXS) over the last 7 years, with Dec 2019 value amounting to $26,000.

  • Astria Therapeutics' Depreciation & Amortization (CF) fell 62.50% to $3,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $26,000, marking a year-over-year decrease of 78.15%. This contributed to the annual value of $26,000 for FY2019, which is 78.15% down from last year.
  • Per Astria Therapeutics' latest filing, its Depreciation & Amortization (CF) stood at $26,000 for FY2019, which was down 78.15% from $119,000 recorded in FY2018.
  • Over the past 5 years, Astria Therapeutics' Depreciation & Amortization (CF) peaked at $395,000 during FY2016, and registered a low of $26,000 during FY2019.
  • In the last 3 years, Astria Therapeutics' Depreciation & Amortization (CF) had a median value of $119,000 in 2018 and averaged $149,667.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first skyrocketed by 95.54% in 2016, then crashed by 78.15% in 2019.
  • Astria Therapeutics' Depreciation & Amortization (CF) (Yearly) stood at $202,000 in 2015, then spiked by 95.54% to $395,000 in 2016, then declined by 23.04% to $304,000 in 2017, then tumbled by 60.86% to $119,000 in 2018, then plummeted by 78.15% to $26,000 in 2019.